News

The company said that the credit facility is available to provide with additional capital as Third Wave executes its plan for leadership in the human papillomavirus (HPV) and

The convertible senior notes mature in 2037 and will pay interest semiannually at a rate of 2% per annum until December 15, 2013, after which their principal will

The patents cover inhaled insulin treatment for diabetes. Detailed terms of the settlement were not disclosed. The lawsuit was originally filed in August 2006 in US Federal Court

The submission maintains the previously proposed global trial design, with clarifications requested by the FDA. The Phase III trial will continue to be a randomized, double-blinded trial, and

The trial showed that SNS-595 was generally well tolerated with anti-leukemic clinical activity when administered either once- or twice-weekly at biologically active doses to patients with relapsed or

The trial is designed to evaluate the safety and efficacy of TRU-015 in subjects with non-Hodgkin’s lymphoma (NHL). The trial is expected to enroll approximately 120 NHL subjects

In this cohort, nine patients received 350mg of bevirimat solution once daily and two patients received placebo for 14 days on top of their failing background regimen. The

The results from study 008, conducted under special protocol assessment (SPA), did not meet the primary endpoint, which was to rule out a best objective response rate of

The company said that BL-5010 is a convenient treatment that offers an alternative to painful, invasive and expensive removal treatments such as surgery, cryotherapy or laser treatment. Because